This publication reports on newly diagnosed cancers registered in England in addition to cancer deaths registered in England during 2020. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document.

Age-standardised rate of mortality from oral cancer (ICD-10 codes C00-C14) in persons of all ages and sexes per 100,000 population.RationaleOver the last decade in the UK (between 2003-2005 and 2012-2014), oral cancer mortality rates have increased by 20% for males and 19% for females1Five year survival rates are 56%. Most oral cancers are triggered by tobacco and alcohol, which together account for 75% of cases2. Cigarette smoking is associated with an increased risk of the more common forms of oral cancer. The risk among cigarette smokers is estimated to be 10 times that for non-smokers. More intense use of tobacco increases the risk, while ceasing to smoke for 10 years or more reduces it to almost the same as that of non-smokers3. Oral cancer mortality rates can be used in conjunction with registration data to inform service planning as well as comparing survival rates across areas of England to assess the impact of public health prevention policies such as smoking cessation.References:(1) Cancer Research Campaign. Cancer Statistics: Oral – UK. London: CRC, 2000.(2) Blot WJ, McLaughlin JK, Winn DM et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7. (3) La Vecchia C, Tavani A, Franceschi S et al. Epidemiology and prevention of oral cancer. Oral Oncology 1997; 33: 302-12.Definition of numeratorAll cancer mortality for lip, oral cavity and pharynx (ICD-10 C00-C14) in the respective calendar years aggregated into quinary age bands (0-4, 5-9,…, 85-89, 90+). This does not include secondary cancers or recurrences. Data are reported according to the calendar year in which the cancer was diagnosed.Counts of deaths for years up to and including 2019 have been adjusted where needed to take account of the MUSE ICD-10 coding change introduced in 2020. Detailed guidance on the MUSE implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/causeofdeathcodinginmortalitystatisticssoftwarechanges/january2020Counts of deaths for years up to and including 2013 have been double adjusted by applying comparability ratios from both the IRIS coding change and the MUSE coding change where needed to take account of both the MUSE ICD-10 coding change and the IRIS ICD-10 coding change introduced in 2014. The detailed guidance on the IRIS implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/impactoftheimplementationofirissoftwareforicd10causeofdeathcodingonmortalitystatisticsenglandandwales/2014-08-08Counts of deaths for years up to and including 2010 have been triple adjusted by applying comparability ratios from the 2011 coding change, the IRIS coding change and the MUSE coding change where needed to take account of the MUSE ICD-10 coding change, the IRIS ICD-10 coding change and the ICD-10 coding change introduced in 2011. The detailed guidance on the 2011 implementation is available at https://webarchive.nationalarchives.gov.uk/ukgwa/20160108084125/http://www.ons.gov.uk/ons/guide-method/classifications/international-standard-classifications/icd-10-for-mortality/comparability-ratios/index.htmlDefinition of denominatorPopulation-years (aggregated populations for the three years) for people of all ages, aggregated into quinary age bands (0-4, 5-9, …, 85-89, 90+)

In 2020, approximately ** men and ** women per 100,000 population died from lung cancer in England and Wales. During the provided time interval, there has been a noticeable decrease in the mortality of lung cancer among men, while the rate among women has remained at similar levels since the year 2000.

Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.

In 2019, approximately ** men and ** women per 100,000 population died from lung cancer in England. The North East of England had the highest mortality from lung cancer for both genders with a rate of approximately ** men and ** women per 100,000 population.

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.

Legacy unique identifier: P00508

The Office for Health Improvement and Disparities (OHID) has updated the mortality profile.

The profile brings together a selection of mortality indicators, including from other OHID data tools such as the https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data" class="govuk-link">Public Health Outcomes Framework, making it easier to assess outcomes across a range of causes of death.

For the March 2023 update, 12 new indicators have been added to the profile:

• mortality rate for deaths due to COVID-19, all ages
• under 75 mortality rate for deaths due to COVID-19
• mortality rate from all cardiovascular diseases, all ages
• mortality rate from heart disease, all ages
• mortality rate from stroke, all ages
• mortality rate from cancer, all ages
• mortality rate from breast cancer, all ages
• mortality rate from colorectal cancer, all ages
• mortality rate from liver disease, all ages
• mortality rate from respiratory disease, all ages
• under 75 mortality rate from lung cancer
• mortality rate from dementia and Alzheimer’s disease, all ages

If you would like to send us feedback on the tool please contact pha-ohid@dhsc.gov.uk.

Mortality from lung cancer (ICD-10 C33-C34 equivalent to ICD-9 162). To reduce deaths from lung cancer. Legacy unique identifier: P00517

In the period 2017 to 2019, the mortality rate from kidney cancer in the United Kingdom was **** deaths per 100,000 men and *** deaths per 100,000 women. Across the overall provided time interval the mortality rate from kidney cancer has increased in the UK, although the rate has been fairly stable in recent years.

This statistic shows the mortality rate per 100,000 population from cervical cancer in England from 2014 to 2021. The mortality rate has declined slightly since 2014 from 2.7 per 100,000 population to 2.5 per 100,000 population in 2021.

Deaths from breast cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

This statistic shows the number of deaths from cervical cancer in England from 2014 to 2021. In 2021, the number of deaths from cervical cancer reached 702, an increase from 681 deaths in 2020.

This statistic shows the rate of mortality to testicular cancer incidence in England in 2016, by region. Testicular cancer occurs when cells in the testis begin to grow abnormally. In this year in the the north east of England 3 percent of males who were diagnosed died as a result of testicular cancer, this was the highest recorded rate in England. The region with the lowest rate of mortality to testicular cancer incidence was the east of England and London at 1 percent.

Mortality from lung cancer (ICD-10 C33-C34 equivalent to ICD-9 162). To reduce deaths from lung cancer. Legacy unique identifier: P00516

Deaths from cervical cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

In the period 2017 to 2019, the mortality rate from melanoma skin cancer in the United Kingdom was *** deaths per 100,000 for men and *** deaths per 100,000 for women. Across the overall provided time interval the mortality rate from skin cancer has increased significantly in the UK, although there has been a slight decline since 2012-2014.

In 2018/19, the mortality rate from non-melanoma skin cancer in the United Kingdom was *** deaths per 100 thousand for men and *** deaths per 100 thousand for women. Across the provided time interval the mortality rate from non-melanoma skin cancer has decreased for women, while the rate for men has experienced more fluctuations but was a higher rate at the start and the end of the provided time interval.

Deaths from prostate cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

Deaths from lung cancer - Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Primary Care Trust (PCT), Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data